Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023
-
EHE HIV Implementation Science Awards Track HRSA Initiatives
New grant awards for the latest round of funding of research on HIV interventions under the Ending the HIV Epidemic Initiative have been announced.News Article updated on 04/12/2024 -
New Tools on Quality Improvement and People with Lived Experience
Participation of people with lived experience in quality improvement work to enhance health outcomes of people with HIV.Blog updated 05/08/2024
-
Is Medicare About to Cover PrEP Under Part B?
Is Medicare going to adopt the practice of private health insurance and start covering PrEP without cost-sharing under Part B?News Article updated on 05/14/2024 -
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
Ryan White HIV Care and Black/African American People
A significant proportion of African Americans living with HIV/AIDS get care from HRSA's Ryan White HIV/AIDS Program.
Blog updated 03/29/2024
-
Ryan White HIV Care and Women and Girls
From 2010 through 2022, viral suppression increased from 66.3% to 89.9% among female RWHAP clients receiving HIV medical care.Blog updated 04/17/2024
-
Ryan White HIV Care and Asian Pacific Islanders
Asians and Native Hawaiian/Pacific Islanders each comprised less than 2% of Ryan White HIV/AIDS Program (RWHAP) clients.
Blog updated 05/24/2024
-
Ryan White HIV Care and Gay/Bisexual Men
Learn about Ryan White HIV care innovations targeted to gay/bisexual men, who comprise nearly half of the program's clients.
Blog updated 03/29/2024
-
Ryan White HIV Care and Latinos
Learn about the Ryan White HIV/AIDS Program's commitment to HIV/AIDS care among Latino populations.
Blog updated 03/29/2024
-
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
Ryan White and Hepatitis/HIV Care
Access these tools on integrating hepatitis screening and treatment within HIV care programs.
Blog updated 05/29/2024
-
Ryan White HIV Care and Youth
The Ryan White HIV/AIDS Program has a rich history as an delivering HIV care to young people, especially hard-to-reach populations.
Blog updated 05/06/2024
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
Evidence-Informed Interventions in Four HIV Care Continuum Manuals
Evidence-informed interventions for engaging persons with HIV in care (incarceration/community release; buprenorphine; patient navigation for women of color; peer linkages for women of color).
Blog updated 01/07/2021
-
Syphilis Cases Continue to Climb
Syphilis cases continue to climb in the U.S. In April 2023, CDC reported a 32% increase in cases from 2020 to 2021 (133,954 to 176.713 cases). In 2022, cases had jumped yet again, to 203,500.News Article updated on 03/04/2024 -
Ryan White HIV Care and Transgender People
Over half a million individuals get HIV care from HRSA's Ryan White HIV/AIDS Program (RWHAP). In 2021, 2.4% were transgender.Blog updated 03/29/2024
-
The Evolution of Ryan White HIV Care
Cross-post of a guest editorial by Dr. Laura Cheever, HRSA Associate Administrator for HIV/AIDS, from Leading with Race, NMAC.
Blog updated 01/07/2021